Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
110 participants
INTERVENTIONAL
2025-11-14
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study population consists of 110 women attending courses at the Suzan and Abdulhakim Bilgili Public Education Center in Onikişubat, Kahramanmaraş, Türkiye, between August 2025 and December 2025. No formal sample size calculation was performed. Instead, 80 women who met the inclusion criteria and voluntarily agreed to participate were included in the study.
Participants were randomly assigned to either the intervention group (education) or the control group (no education). The HPV education program is delivered in two 1-hour sessions using PowerPoint presentations and informational brochures developed from current literature and reviewed by experts in women's health nursing.
Data are collected before and after the educational sessions using a Personal Information Form and the HPV Knowledge Scale (HPV-KS), which measures participants' knowledge about HPV infection, vaccination, and screening. Statistical analyses will be conducted using SPSS 22.0, with descriptive statistics and inferential tests (paired-sample t-test, independent-sample t-test, repeated-measures ANOVA, and non-parametric equivalents) applied as appropriate. A p-value \< 0.05 will be considered statistically significant.
It is hypothesized that women receiving HPV education will demonstrate significantly higher post-intervention knowledge scores compared to those in the control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake
NCT07320157
The Effects of Health Education About Human Papilloma Virus and Cervical Cancer Prevention on Knowledge, Attitudes, Beliefs and Behaviors
NCT04113902
Impact of Education Methods on HPV Knowledge and Screening Behavior
NCT07017387
HPV Education, Early Diagnosis and Knowledge
NCT06464523
Peer Education on HPV: Impact on Health Sciences Students' Knowledge, Awareness, and Concern
NCT06909370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Cervical cancer remains one of the leading health concerns worldwide in terms of mortality and morbidity rates. The high incidence, insufficient HPV screening, and low awareness of HPV indicate the widespread presence of HPV infection . Increasing public awareness, preventing disease occurrence, and implementing protective planning and educational interventions are of great importance. One of the key strategies for addressing cervical cancer is to promote HPV screening .
In Türkiye, several studies have been conducted to assess the level of knowledge about HPV and its vaccine among healthcare personnel and students in health-related fields. The results of these studies have shown that participants' knowledge about HPV is not at the desired level . These studies revealed deficiencies in fundamental areas such as HPV-related infections, vaccination methods, and the effectiveness and importance of the vaccine. Such knowledge gaps may limit healthcare professionals' ability to provide effective health services and raise public awareness regarding HPV. Similarly, studies evaluating women's knowledge, attitudes, and behaviors about HPV and its vaccine have generally shown that women's knowledge of HPV is low
Therefore, HPV education is considered highly important. Educational programs can help participants make informed decisions and protect their sexual health. The findings obtained from such programs may guide the implementation of similar initiatives for larger communities and increase awareness about HPV. These kinds of studies play a crucial role in designing preventive measures and awareness-raising programs for public health, while also contributing to the limited existing literature. Accordingly, this study aims to examine the effect of HPV education provided to women on their level of knowledge regarding human papillomavirus.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HPV Awareness Education Group
HPV Awareness Education Group
Women who agree to participate in the training will receive a total of two hours of HPV awareness training in two sessions on the predetermined training date. The HPV awareness training will be delivered using a PowerPoint presentation, and at the end of the training, a brochure created in line with the literature will be distributed to the participating women to ensure retention. The brochure will be prepared by the researcher based on current literature sources. Expert opinions will be sought from specialists in the field of obstetrics and gynecology nursing regarding the training content, and revisions will be made if necessary. The training content will include the definition of HPV, risk factors, etiology, screening, HPV vaccination, transmission and prevention methods, and treatment. The training topics will be prepared by the faculty members responsible for the research in accordance with the literature.
Control Group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HPV Awareness Education Group
Women who agree to participate in the training will receive a total of two hours of HPV awareness training in two sessions on the predetermined training date. The HPV awareness training will be delivered using a PowerPoint presentation, and at the end of the training, a brochure created in line with the literature will be distributed to the participating women to ensure retention. The brochure will be prepared by the researcher based on current literature sources. Expert opinions will be sought from specialists in the field of obstetrics and gynecology nursing regarding the training content, and revisions will be made if necessary. The training content will include the definition of HPV, risk factors, etiology, screening, HPV vaccination, transmission and prevention methods, and treatment. The training topics will be prepared by the faculty members responsible for the research in accordance with the literature.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agreeing to participate in the study,
* Not experiencing communication difficulties,
* Female students who complete the data collection form in full will be included in the study.
Exclusion Criteria
* History of cervical cancer
* Unreachable
* Not attending public education during the training period
* Female students who did not complete the data collection form will be excluded from the study.
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kahramanmaras Sutcu Imam University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatma Keskin Töre
ASSOCIATE PROFESSOR
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
1. World Health Organization-WHO. Updates recommendations on HpV vacci- nation schedule
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025/23/04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.